Atara Biotherapeutics Inc
ATRA
Market Cap$82.56M
Close$
$2.35
231.3% upside
Current Fair Value
231.3% upsideUndervalued by 231.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $82.56 Million |
|---|---|
| Enterprise Value | $76.53 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.61 |
| Beta | 2.95 |
| Outstanding Shares | 119,359,230 |
| Avg 30 Day Volume | 1,156,101 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | 1.58 |
| Price to Sales | - |
| Price to Book Ratio | -0.71 |
| Enterprise Value to Revenue | 8.93 |
| Enterprise Value to EBIT | -0.28 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | -0.46 |
Revenue Sources
No data
ESG Score
No data
About Atara Biotherapeutics Inc
CEO: Pascal Touchon